General informations

Vladimir Jurisic , MD, PhD
Born: May 1964, Yugoslavia


Education Background




Scientific projects


Editorial board in National Journal

1. Archive of Oncology, University of Novi Sad, Institute of Oncology, Serbia
2. PONS, Journal of General Medicine, National Institute of Health, Serbia
Editorial board in International Journal

1. Journal of Infectious Diseases and Immunity

2. Journal of hematological malignancies

3. Indian Journal of Fundamental and Applied Life Sciences

4. International Journal of Internal Medicine




Article in International journals:









  1. Colović N, Peruničić M, Jurišić V, Colović M. Specific skin lesions in hairy cell leukemia at presentation: case report and review of literature. Medical Oncology, 2010, 27(2):559-61.
  1. Colovic N, Jurisic V, Terzic T, Atkinson HD, Colovic M. Chemoimunotherapy for Bcl-2 and MUM negative aggressive primary cutaneous B-cell non-Hodgkin’s lymphoma. Archive of Dermatology Research, 2009, 301(9):689-92.


  1. Konjevic G, Martinovic M K, Jurisic V, Babovic N, Spuzic I. Biomarkers of suppressed natural killer cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptor on CD3-CD16+ NK cells. Biomarkers, 2009, Vol. 14, 4, 258-270.
  1. Jurisic V, Pavlović S, Čolović N, Djordjević V, Bunjevački V, Janković G, Čolović M. Single Instutute study of FLT3 Mutation in Acute Myeloid Leukemia with ear Tetraploidy in Serbia. Journal of Genetics, 2009, 88(2):149-52.


  1. Jurisic V, Terzic T, Colic S, Jurisic M. The concentration of TNF –α correlated with number of inflammatory cells and degree of vascularisation in radicular cysts. Oral Disease, 2008, 7, 600-605.
  1. Jurisic V, Terzic T, Pavlovic S, Colovic M. Elevated TNF alpha and LDH associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis. Pathology-Research and Practise, 2008, 204, 129-132.


  1. Jurisic V, Colovic N Kraguljac N, H.D Atkinson, Colovic M. Analysis of CD23 antigen expression in B-chronic lymphocytic leukemia and its correlation with clinical parameters. Med Oncology 2008, 25(3), 315-322.
  1. Colovic N, Jurisic V, Colovic M. Malignant histiocytosis with central nervous system involvement in single patients with review of literature. Journal of BUON, 2007, 12, 539-542.


  1. Jurisic V, Colic S, Jurisic M. Difference in TNF-α between radicular and keratocyst (odontogenic tumour) in maxillofacial region. Acta Medica (Hradec Kralove), 2007, 50(4), 233-238.   
  1. Bogdanovic G, Jakimov D, Stojiljkovic B, Jurisic V. The cell growth, morphology and immunocytochemistry of novel cell line established from a bone marrow of the patients with therapy related-myelodisplastic syndrome, entitled PC-MDS. Med Oncology, 2007, 24:419-424.


  1. Jurisic V, Srdic T, Konjevic G, Markovic O, Colovic M. Clinical stage-depending increase of NK cell activity in multiple myeloma patients. Med Oncology 2007, 24, 312-327.
  1. Popovic B, Jekic B, Novakovic I, Lukovic LJ, Tepavcevic Z, Jurisic V, Vukadinovic M, Milasin J.  Bcl-2 expression in oral squamous cell carcinoma. Ann N Y Acad Sci, 2007; 1095:19-25


  1. Bogdanovic G, Jurisic V, Kraguljac N, Mrdjanovic J, Jakimov D, Krtolica K, Dragic M, Magic Z, Stoiljkovic B, Andrejevic Lj, SrdicT, Baltic M, Popovic S. characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy related myelodisplastic syndrome. Leukemia Research, 2007, 31, 1105-1113.
  1. Konjevic G, Mirjacic-Martinovic K, Vuletic A, Jovic V, Jurisic V, Babovic N, Spuzic I. Low expression of CD161 and NKG2D activating receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients. Clinical Experimental Metastasis. 2007,24, 1-11.


  1. Bakrac M, Jurisic V, Kostic T, Popovic V, Pekic S, Kraguljac N and Colovic M. Pure red cell aplasia associated with type I autoimmune polyglandular syndrome: successful response to therapy with mycophenolate mofetil: case report and review of literature, Journal of Clinical Pathology, 2007, 60, 715-736.
  1. Colovic M, Jurisic V, Pavlovic S, Terzic T, Colovic N. FLT3/D835 mutation and inversion of chromosome 16 in leukemic transformation of myelofibrosis. European Journal of Internal Medicine, 2006, 17, 434-435.


  1. Colovic M, Jurisic V, Jankovic G, Jovanovic D, Dimitrijevic J. Interferon a sensibilization-induced fatal renal insufficiency in a patient with chronic myeloid leukemia. Case report and review of literature. J Clinical Pathology, 2006, 59, 879-881.
  1. Jurisic V, Bogdanovic G, Kojic V, Jakimov D, Srdic T. TNF-alpha effects on Raji cells at different cellular level estimated by various methods. Annals of Haematology, 2006, 85; 86-94.


  1. Jurisic V, Kraguljac N, Konjevic G, Spuzic I. TNF-a induced changes in cell membrane antigen expression on K-562 cells is associated with increased LDH release. Neoplasma, 2005, 1, 25-32.
  1. Jurisic V, Bogunovic M, Colovic N, Colovic M. Indolent course of cutaneous Hodgkin disease. Journal of Cutaneous Pathology, 2005, 32, 176-178.


  1. Jurisic V, Bogdanovic G, Srdic T, Jakimov D, Mrdjanovic J, Baltic M, Baltic V.V. Modulation of TNF-a activity in tumor PC cells using anti-CD45 and anti CD95 monoclonal antibody. Cancer Letters, 2004, 214, 55-61.
  1. Jurisic V, Konjevic G, Jancic-Nedeljkov R, Sretenovic M, Banicevic B, Colovic M, Spuzic I. The comparison of spontaneous LDH release from cultured PBMC with sera LDH activity in Non-Hodgkin’s lymphoma patients. Medical Oncology, 2004, 21, 179-185


  1. Jurisic V, Bumbasirevic V, Konjevic G, Djuricic B, Spuzic I. TNF-alpha induced changes in LDH isotype profile following triggering of apoptosis in PBMC of non-Hodgkin’s lymphoma. Annals of Haematology, 2004, 83, 84-91.


  1. Konjevic G, Jovic V, Jurisic V, Jelis S, Radulovic S, Spuzic I. IL-2-mediated augmentation of NK cell activity and activation antigen expression on NK and T cell subsets in patients with metastatic melanoma treated with interferon-a and DTIC. Clinical and Experimental metastasis, 2003, 20 (7):647-655
  1. Jurisic V. Estimation of cell membrane alteration after drug treatment by LDH release. Blood, 2003, 101, 2894.


  1. Jurisic V, Jancic-Nedeljkov R, Konjevic G, Spuzic I. Decrease of NK cell activity and characteristics of peripheral blood mononuclear cells (PBMC) in a haemochromatosis. Haema, 2003, 6, 85-88.
  1. Jurisic V, Colovic M. Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta-2 microglobulin, and clinical stage in multiple myeloma, Medical Oncology, 2002, 19(3), 133-139  


  1. Konjevic G, Jurisic V, Spuzic I. Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients. Breast Cancer Res Treat. 2001, 66(3): 255-263.
  1. Jurisic V, Konjevic G, Banicevic B, Djuricic B, Spuzic I. Different alterations in lactate dehydrogenase (LDH) activity and profile of peripheral blood mononuclear cells in Hodgkin’s and Non-Hodgkin’s lymphomas. Eur. J. Haematology, 2000, 64: 259-266.


  1. Jurisic V, Spuzic I, Konjevic G. A comparison of NK cell activity with effects of TNF-alpha against K-562 cells, determined by LDH release assay. Cancer Letters, 1999, 138: 67-72.
  1. Konjevic G, Jurisic V, Banicevic B, Spuzic I, Difference in NK cell activity between patients with non-Hodgkin’s lymphoma and Hodgkin’s disease. Br. J. Haematology, 1999, 104: 144-151.


  1. Konjevic G, Jurisic V, Spuzic I. Correction to the original lactate dehydrogenase (LDH) release assay for evaluation of NK cell cytotoxicity. J. Immunol. Methods, 1997, 200: 199-201
  1. Konjevic G, Spuzic I. Jurisic V. In-vitro effects of cytokines and cytokines receptors on the activity of NK cells. Journal of B.O.U.O.N. 1996, 1(1): 47-52


International book/editions:

  1. Jurisic V, Samardzic G, Colic S, Jurisic M. TNF-a in radicular and otontogenic cysts. 6th Vienna, Austria, In Monduzzi Editore, Bolona, 2006,


  1. Konjevic G, Jurisic V, Spuzic I. In-vitro effects of cytokines and cytokines receptors on the activity of NK cells. In Atypas G ed: Balkan Congress of Oncology, Monduzzi Editore, Bolona, 1996, 9-11.

Publications in national Journals:


  1. Perišić M Jurišić V, Kerkez M. Doppler ultrasonography of hepatic artery in malignant liver tumors. Archive of Oncology, vol. 16, br. 3-4, str. 46-48, 2008.
  1. Jurišić V. Bumbaširević V. In vitro assays for cell death determination. Archive of Oncology, vol. 16, br. 3-4, str. 49-54, 2008.


  1. Colovic N, Jurisic V, Colovic M. Rituximab for primary cutaneous large B cell non Hodkins lymphoma. Archive of Oncology, 2008, 2, 16
  1. Jurisic V, Sladjana Stojacic-Djenic, Colovic N, Konjevic G. Effects of cytokines on NK cell activity. Srp Arch Celok, Lek, 2008, 7 136, 423-429. (Review article).


  1. Stojačić-Đenić S., Kerkez M., Jović D., Maksimović Ž., Jeftović I., Milić Ž., Perišić M., Jurišić V. Uporedna analiza ultrasonografije i mamografije sa histološkim nalazom dobijenim ex tempore u dijagnostici tumora dojke. Acta chirurgica Iugoslavica, vol. 55, br. 4, str. 37-41, 2008.
  1. Colic S, Jurisic M, Jurisic V. Pathophysiological mechanism of the developing radicular cyst of the jaw.  Acta Chirurgica Iugoslavica, 2008;55(1):87-92. (review article)


  1. Jurisic V, Colovic N, Pavlovic S, Colovic M. Diffuse osteolytic lesions in leukemic transformation of myelofibrosis. Archive of Oncology, 2007, 15, 13-17.
  1. Stojacic-Djenic S, Sarenac-Kovac R, Kerkez M, Jurisic V. Doppler hemodynamic study in evaluation of liver metastasis. Acta Chirurgica Iugoslavica, 2007, 2, 9-13.


  1. Jurisic V. Characteristic of NK cell activity. Srp Arh Celok Lek. Belgrade, 2006, 134, 71-76 (review article).
  1. Jurisic V, Kraguljac N, Banicevic B. Imunofenotipske karakteristike tokom transformacije Non-Hodgkinskih Limfoma (NHL) u B-hroničnu limfocitnu leukemiju (B-CLL). Pons, 2005, 2, (1)15-18.


  1. Jurisic V, Radosavljavic N, Jeftovic I, Perisic M. The problems in early diagnosis of breast cancer patients in general hospital. Pons, 2005,
  1. Colovic M, Jurisic V, Colovic N, Miljic P. Thrombocytic thrombocitopenic purpura: The clinics and pathology characteristics in terms of treatment, review article. Srpski archive za celokupno lekartsvo, 2003, 131, (7-8): 337-345. 


  1. Lazic P, Jurisic V, Perisic M. Problems in early diagnosis of the loco-regional breast cancer in general hospital. Archive of Oncology, 2002, 6:
  1. Konjevic G, Jurisic V, Jakovljevic B, Spuzic I. Lactate dehydrogenase (LDH) in peripheral blood lymphocytes (PBL) of patients with solid tumors. Glas SANU, 2002, 47: 137-147.


  1. Jurisic V. Biology and physiology of NK cells (review article). Medicus, 2001, (4): 1-7.
  1. Jurisic V, Bogdanovic G, Srdic T, Kerenji A, Baltic M, Baltic V. V. The activity of TNF-alpha on PC cells pre-labelled with anti-CD45 and CD95 monoclonal antibodies. Archive of Studenica, 2000, 2: 56-59


  1. Jurisic V, Jancic-Nedeljkov R, Konjevic G, Spuzic I. Characteristics of peripheral blood mononuclear cells (PBMC) and suppression of NK cell activity in a woman with chemochromatosis. Medicus, 2000, 1: 20-23.
  1. Jurisic V, Konjevic G, Bumbasirevic V, Djuricic B, Spuzic I. TNF-a effects on induction of apoptosis on malignant lymphoma peripheral blood lymphocytes. Archive of Studenica. 1998,1: 49-52.

 National Book’s chapters:





Cited Reference Search


215 cited references found in 2010 by Scopus base
Cited Author=JURISIC V